Precision NanoSystems to Launch the Revolutionary Ignite – BSA bureau

Posted on by

Vancouver BC, Oct 09, 2019 -- Precision NanoSystems (PNI) a global leader of innovative solutions for the discovery, development, and manufacture of nanomedicine based gene and cell therapies, small molecule and protein based drugs is pleased to introduce our newest member of the Nanoassemblr Platform: the IgniteTM available October 15, 2019.

The Ignite embodies everything that made the NanoAssemblr family of instruments the go-to platform for developing new Precision and Gene Therapy medicines for over 100 biopharma companies and featured in over 150 publications. said James Taylor, CEO & Co-Founder PNI. The Ignite brings our latest innovations developed for clinical manufacturing to the bench, and paves the way for new nanomedicine approaches to treat cancer, rare disease and infectious disease.

PNIs proprietary NxGenTM scalable continuous-flow microfluidic technology is at the heart of the NanoAssemblr family, using controlled mixing to reproducibly manufacture the highest quality drug products through a single mixer across scales. Ignite enables rapid benchtop scale development of nanoparticle based RNA, DNA, CRISPR, small molecule and protein therapeutics. Optimized drug products are predictably scaled to advanced preclinical and clinical scale with the NxGen technology on the NanoAssemblr BlazeTM and GMP Systems.

As the leading provider of RNA/DNA drug manufacturing, we designed Ignite with the end in mind developing a robust, scalable process from the earliest stage. Enabling researchers to create transformative medicines at the bench scale, said Euan Ramsay, CCO & Co-Founder PNI.

Excerpt from:
Precision NanoSystems to Launch the Revolutionary Ignite - BSA bureau

Precision NanoSystems to Launch the Revolutionary Ignite – GlobeNewswire

Posted on by

IgniteEnables Transformative Medicines: Designed with the End in Mind, Designed for the Future, Designed to Maximize Time

Vancouver BC, Oct. 09, 2019 (GLOBE NEWSWIRE) -- Precision NanoSystems (PNI) a global leader of innovative solutions for the discovery, development, and manufacture of nanomedicine based gene and cell therapies, small molecule and protein based drugs is pleased to introduce our newest member of the Nanoassemblr Platform: the Ignite availabe October 15, 2019.

The Ignite embodies everything that made the NanoAssemblr family of instruments the go-to platform for developing new Precision and Gene Therapy medicines for over 100 biopharma companies and featured in over 150 publications. said James Taylor, CEO & Co-Founder PNI. The Ignite brings our latest innovations developed for clinical manufacturing to the bench, and paves the way for new nanomedicine approaches to treat cancer, rare disease and infectious disease.

PNIs proprietary NxGen scalable continuous-flow microfluidic technology is at the heart of the NanoAssemblr family, using controlled mixing to reproducibly manufacture the highest quality drug products through a single mixer across scales. Ignite enables rapid benchtop scale development of nanoparticle based RNA, DNA, CRISPR, small molecule and protein therapeutics. Optimized drug products are predictably scaled to advanced preclinical and clinical scale with the NxGen technology on the NanoAssemblr Blaze and GMP Systems.

As the leading provider of RNA/DNA drug manufacturing, we designed Ignite with the end in mind developing a robust, scalable process from the earliest stage. Enabling researchers to create transformative medicines at the bench scale, said Euan Ramsay, CCO & Co-Founder PNI.

We are hitting the road and showcasing this revolutionary technology in a location near you. Find localWorkshopsor see Ignite and our complete NanoAssemblr Platform at theseconferences in 2019.

About: PNIs proprietary NanoAssemblr Platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments,reagents and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology.

Originally posted here:
Precision NanoSystems to Launch the Revolutionary Ignite - GlobeNewswire

Start-up of the week: charging your car can be done in minutes – Innovation Origins

Posted on by

Your sneak preview of the future is the slogan of Innovation Origins, and thats just what we will highlight with our Start-up of the Week column. Over the past few days, five start-ups of the day have been featured and on Saturday we will choose the weeks winner.

Innovation Origins presents a Start-up of the Day each weekday

We shall consider various issues such as sustainability, developmental phase, practical application, simplicity, originality and to what extent they are in line with theSustainable Development Goals of UNESCO. They will all pass by here and at the end of the week, the Start-Up of the Week will be announced.

Moreover, our weekly winners may be awarded another prize. Because at the end of each calendar month, our readers, together with the editors of IO, will select the Start-up of the Month!

The way we use medicines is still somewhat primitive. Maybe thats not surprising, because our options are limited when it comes to taking medication. Most organs are well protected from the outside world. Nevertheless, this also means that medicines cannot be administered very effectively. Dosages are therefore often higher than necessary because they have to travel a long way through our bodies.

Sovigo wants to change this through nanotechnology. Their capsules are about 100 nanometres in size, which is 10,000th of a millimeter (!) The main advantage is that this nanomedicine is effective solely at the point where the medication is actually needed. Preliminary results are encouraging for treating intestinal disorders.

Climate change and dwindling agricultural land are major challenges for food and feed production. The supply of animal protein is particularly problematic.

The start-up Blue Planet Ecosystems, based in San Francisco and Vienna, wants to shift pisciculture (fish farming) to computerized container systems. The ecosystem is to be simulated in such a way that nature is able to grow in self-sustaining LARA systems (Land-based Automated Recirculating Aquaculture).

Lara Systeme (c) Blue Planet Ecosystems

This German start-ups drone system has brought a new automation revolution to warehouses. The flying assistants are able to make an inventory of a warehouse on their own by making a kind of digital impression of it. At present, maintaining a warehouse is a time-consuming task. Doks. Innovation promises a time gain of no less than 90% and a cost reduction of 80%. Data collected by the drones are subsequently made available in a proprietary data analysis system. Similar concepts are focused on a single management system as a rule, whereas Doks offers a universal system.

Giving freedom back to people who have limited freedom of movement. Thats the noble goal that former snowboarder Patrick Mayer has committed himself to. Mayer ended up in a wheelchair for a long time himself and personally experienced how winter can throw a spanner in the works. Moving through snow and over ice in a wheelchair or with crutches is just not much fun.

Which is why he came up with Wheelblades, a kind of mini-snowboard that gives more stability to the front wheels. For people on crutches, there is the SafetyFoot, an extra foothold for underneath crutches. And Wheelblades are also suitable for prams, so that you are able to go on a winter hike with your little one without any hassles.

Recharging: it is perhaps the greatest sore point that is associated with electric mobility. Compared to traditional refueling, it takes ages before you can get back on the road. If its up to the Israeli start-up Chakratec, this will soon be a thing of the past. Their kinetic battery fills up about as fast as your diesel tank does. Yet the potential is even greater: the battery has unlimited charging cycles and contains no pollutants.

They are setting their sights on a heroic reputation. A start-up for the benefit of humankind. What makes this mission even more challenging, is that the market in which they have delved into is dominated by Chinese companies. How do you stand out? The solution is simple and difficult at the same time. Come up with something completely new. The result is a kinetic battery with flywheel technology.

A battery can be highly innovative; but without a good charger it is of little use. Chakratec maintains that current infrastructure has been overwhelmed by reality and is suffering from too much red tape. It would be possible to create fast charging stations anywhere, even with a weak network, with the relevant fast charging technology.

The potential of Chakratecs technology has not gone unnoticed. The start-up has already won several awards, including one for best storage technology. They can add another feather in their cap because the favorable prospects for Chakratec make it the Start-up of the Week!

There is a frantic search going on around the world for efficient and sustainable batteries and the subject is also regularly addressed by Innovation Origins. At the beginning of this month, for example, we spoke to the start-up High Performance Battery, which is also trying to bring a new type of smartphone battery onto the market. Or does the future for cars lie with hydrogen technology? We sought answers to that question here in this series.

Innovation Origins is an independent news platform, which has an unconventional revenue model. We are sponsored by companies that support our mission: spreading the story of innovation. Read more here.

On Innovation Origins you can always read articles for free. We want to keep it that way. Have you enjoyed this article so much that you want to contribute to independent journalism? Click here:

Originally posted here:
Start-up of the week: charging your car can be done in minutes - Innovation Origins

Rising adoption of minimally invasive treatments for chronic disorders across the globe will propel the growth of injectable nanomedicines market…

Posted on by

The globalinjectable nanomedicines markettouched USD 479.6 million in 2017, and is expected to reach USD 833.9 million by 2025, growing at a CAGR of 7.3% during 20182025.

Source: GMI Research

Major Factors driving the market growth are: Growing incidence of chronic diseases like cancer, cardiovascular diseases, neurological disorders Increasing research & development activities and clinical trials Rising demand and adoption of minimally invasive treatments Rising government and private funding Increasing geriatric population

Growing demand for minimal invasive treatments is driving the Injectable Nanomedicines market. Introduction of innovative and advanced nanotechnology and nanomedicines, especially in the emerging markets with the help of government and private funding would spur the growth of market for the injectable nanomedicines during the forecast period.

Request for Sample Report https://www.gmiresearch.com/report/global-injectable-nanomedicines-market-by-product/sample-request

A paradigm shifts from traditional therapeutics to novel therapeutics using nanomedicines is propelling the overall market as nanomedicines have higher payload capacity, prolonged blood circulation times, reduced toxicity and improved anti-tumour efficacy. Moreover, the application of injectable nanomedicines for some widespread chronic diseases like migraine and depression is also aiding market growth. The use of injectable nanomedicines are found to be efficient, lasting and easy treatment of many chronic cardiovascular and neurological disorders.

Growing incidence rate due to aging demographic patterns and the extension of health insurance coverage in a developing region will support the market growth. Advancements in cancer drug delivery and personalized cancer treatments, effective and safe treatment of medically refractory movement disorders and the need for fast and efficient cardiovascular systems will primarily drive the global injectable nanomedicine market.

The rising pool of patients of chronic diseases and the need for a fast, efficient and long-lasting treatment with minimal invasion procedures will drive the injectable nanomedicines market.-GMI Research

Based on geography, North America held the largest market share in 2017 due to the significantly high rate of incidence of cancer as well as cardiovascular diseases in the region. Currently, the region has a growing demand for rapid research & development of novel nanomedicine in order to address unmet medical needs. Furthermore, favourable reimbursement policies and increasingly growing partnerships between leading enterprises and nanomedicine start-ups is also expected to create growth opportunities. Europe is the second largest market in 2017 and is promising market due to developed healthcare system and rising adoption of nanomedicine in oncology sector. Asia-Pacific is expected to show promising growth in global injectable nanomedicines during 2018-2025 due to the increasing government and private funding for health care infrastructure along with the rising incidence of neurological disorders. Moreover, increasing adoption of nanomedicine for the treatment of cancer, diabetes, cardiovascular diseases and some infectious disease in the Asia-Pacific region would also contribute significantly to the market growth for injectable nanomedicines in the region.

Based on geography, North America held the largest market share in 2017 due to the significantly high rate of incidence of cancer as well as cardiovascular diseases in the region. Currently, the region has a growing demand for rapid research & development of novel nanomedicine in order to address unmet medical needs. Furthermore, favourable reimbursement policies and increasingly growing partnerships between leading enterprises and nanomedicine start-ups is also expected to create growth opportunities. Europe is the second largest market in 2017 and is promising market due to developed healthcare system and rising adoption of nanomedicine in oncology sector. Asia-Pacific is expected to show promising growth in global injectable nanomedicines during 2018-2025 due to the increasing government and private funding for health care infrastructure along with the rising incidence of neurological disorders. Moreover, increasing adoption of nanomedicine for the treatment of cancer, diabetes, cardiovascular diseases and some infectious disease in the Asia-Pacific region would also contribute significantly to the market growth for injectable nanomedicines in the region.

Key takeaways/key essentials: In 2017, the cancer treatment held the major share for the injectable nanomedicines market followed by the cardiovascular diseases segment. High demand and adoption rate for minimally invasive treatments in the recent past. Extended research and development activities are taking place using the injectable nanomedicines regarding the concept of targeted drug delivery system.

Some of the key players operating in the global market for injectable nanomedicines include Merck & Co., Inc., Lupin, Pacira Pharmaceuticals Inc., Celgene Pharmaceutical Co. Ltd., Amgen, Inc., Janssen Biotech Inc., Pfizer Inc., Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch & Lomb Inc. among others.

Theglobalinjectable nanomedicines markethas been segmented based on product type, indication type and key geographies. Based on the product type, global injectable nanomedicines market has been segmented into liposomes, micelles, nanocrystals and others. Based on indication type, the market has been segmented into cancers, central nervous system diseases, cardiovascular diseases, inflammatory diseases and others.

The research report global injectable nanomedicines market provides in-depth analysis of injectable nanomedicines market, globally, based on product type, indication and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers fuelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for injectable nanomedicines market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, browse the Table of Contents:https://www.gmiresearch.com/report/global-injectable-nanomedicines-market-by-product/

Early buyers will get customization upto 20% on report

About GMI Research

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

Media Contact

Company Name: GMI RESEARCHContact Person: Media RelationsPhone: +353 1 442 8820Address:Level 1, The Chase Carmanhall Road, Sandyford Industrial EstateCity: DublinState: DublinCountry: IrelandWebsite:www.gmiresearch.com

Originally posted here:
Rising adoption of minimally invasive treatments for chronic disorders across the globe will propel the growth of injectable nanomedicines market...

Nanomaterials in Theranostics Market by Segmentation: Based on Product Application and Region 2016 2024 – Space Market Research

Posted on by

Global Nanomaterials in Theranostics Market: Overview

The application of theranostics in nanomedicine is a fast emerging paradigm, which involves the use of nanoparticles or nanoscale materials for a variety of diagnostic, imaging, and therapeutic applications. Recent research efforts have been increasingly focused on designing functional nanomaterials for non-invasive imaging of diseases, including bioimaging and biosensing, advanced biomarkers, and targeted delivery of therapeutic drugs. Efforts are also underway for developing highly biocompatible nanoplatforms for various theranostic nanomedicine applications.

Several nanomaterials in theranostics have proven promising for the treatment of chronic and fatal diseases such as cancer, AIDS, and various types of cardiovascular diseases. Adequate surface modifications are being made in a variety of polymeric and inorganic nanoparticles to enhance their conjugation with biomolecules and their interactions with target tissues. As a result, the market is witnessing the development of various classes of nanoscale particles with reduced cytotoxicity and advanced therapeutic applications, improving the quality of life for patients.

The report offers in-depth insights into the key market dynamics, current trends, and recent technological advances in nanomaterials, emerging theranostics applications, lucrative avenues, and competitive dynamics. The research study takes a closer look at several cross-disciplinary researches in drug discovery and highlights major developments in nanomaterials by leading players for expanding theranostics applications.

Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/nanomaterials-theranostics-market.html

Global Nanomaterials in Theranostics Market: Trends and Opportunities

The rising incidence of chronic and life-threatening diseases, coupled with the need for improving disease detection, and the demand for advanced chemotherapeutic treatments are the key factors propelling the market. The growing potential of clinically translatable nanomaterials in the areas of biological imaging and therapy is anticipated to boost the market. Continuous researches in improving the biocompatibility of a range of nanoparticles, mainly through appropriate surface modification, has fuelled the demand for nanomaterials in theranostics.

In addition, increasing applications of nanoparticles for effective target-specific drug delivery has stimulated their applications in hyperthermia-based cancer treatments, thereby bolstering the demand for nanomaterials in theranostics. Some of the most common classes of nanoparticles used in theranostic applications are gold nanoparticles, mesoporous silica nanoparticles, quantum dots, and nanocrystals. However, lack of favorable regulatory framework, stringent approval requirements, and spiraling developmental costs are some of the key factors likely to hinder the nanomaterials in theranostics market to an extent. Nevertheless, recent partnerships and collaborations between several pharmaceutical and medical devices companies and substantial investments of biotech companies in nanoparticles are expected to unlock abundant opportunities for market players over the forecast period. Furthermore, the application of carbon-based nanoparticles for making a wide range of drug delivery systems is expected to open up lucrative avenues in the coming years.

Global Nanomaterials in Theranostics Market: Regional Outlook

North America is one of the major markets for nanomaterials in theranostics. In the U.S., the theranostic witnesses wide applications in biosensing, bioimaging, and targeted drug delivery. Recent translational researches in the region have expanded the potential of theranostic nanomedicine for a variety of diseases, thereby boosting the nanomaterials in theranostics market. In addition, a robust awareness among patients and clinicians in the efficacy of nanomaterials in theranostics, and aggressive efforts by manufacturers to market their products are expected to catalyze growth. Europe is another prominent market for the demand for nanomaterials in theranostics. The substantial growth of this regional market can be attributed to growing number of product approvals and vast unmet market needs.

Request For Custom Research At https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1682&source=atm

Asia Pacific is expected to show vast opportunities for numerous manufacturers and vendors. This is attributed to increased focus on R&D activities in nanoparticles, cheap procurement of raw materials, and a rapidly rising patient population pool.

Companies mentioned in the report

Companies vying for a sustained share in the nanomaterials in theranostics market include Abalonyx, Nanomat, Inc. Affymetrix, Aldlab Nanotech, Berkeley Advanced Biomaterials, Inc., ACS Materials, AMAG Pharmaceuticals, Inc., Applied Graphene Materials plc, A.P. Pharma, Inc., Monogram Biosciences Inc., Nanocarrier Co. Ltd., Liquidia Technologies, Inc., and Advanced Proteome.

Leading players are resorting to acquisitions and collaborations to consolidate their positions across major regions.

Major regions analyzed under this research report are: North America Europe Asia Pacific Rest of the World (RoW)

This report gives you access to decisive data such as: Market growth drivers Factors limiting market growth Current market trends Market structure Market projections for the coming years

Key highlights of this report Overview of key market forces propelling and restraining market growth Up-to-date analyses of market trends and technological improvements Pin-point analyses of market competition dynamics to offer you a competitive edge An analysis of strategies of major competitors An array of graphics and SWOT analysis of major industry segments Detailed analyses of industry trends A well-defined technological growth map with an impact-analysis Offers a clear understanding of the competitive landscape and key product segments

Request for TOC of This Report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1682&source=atm

Continue reading here:
Nanomaterials in Theranostics Market by Segmentation: Based on Product Application and Region 2016 2024 - Space Market Research

Nanomedicine Conferences 2019 | Nanotechnology Meetings …

Posted on by

Pharmaceutical Nanotechnology & Nanomedicine Congress 2020

LexisConferencesconsider it a privilege and a matter of great pride to host Conference on Pharmaceutical Nanotechnology & Nanomedicine Congressis to be held at Venice, Italyfor the duration of May 11-12, 2020. On this auspicious occasion, Organizing Committee invites the participants from all over the world to take part in this annual flagship conference with the theme Exploring the Progress of Nanomedicinewith Trending Nanotechnologies. The conference will provide a forum for interaction among attendees on Pharmaceutical Nanotechnology, Development of Nanotechnology-enabled Devices, Micro Fluidics platform for Nano Particle Synthesis, Toxicology and Risk Assessment of Nanomedicine Systems, MedicalNano Devices and Biosensors, Synthesis of Nanoparticles for Drug Delivery, Nanomedicine for Immune System and Cancer Diagnosis & Therapy.

This global meeting will assemble the world leaders in the expanding fields related to Pharmaceutical Nanotechnology & Nanomedicine. It will create an interface among professionals, academic faculty members, Researchers, Nanotech representatives and students, Nanotechnologists, Manufacturing Medical Device and experts in the fields of Nanotechnology. industry practitioners.The Conference will also have a room for companies and/or institutions to present their services, products, revolutions and research results.

Global Market for Nanotechnology products was priced $22.9 billion in 2013 and unanticipated increased to about $26 billion in 2014. This market is await to reach about $64.2 billion by 2019; a compound annual growth rate (CAGR) is 19.8% from 2014 to 2019. The global market for nanotechnology-enabled printing technology was approximate to be at total $14 billion in 2013. The market is anticipate to grow at a compound annual growth rate (CAGR) of 17.7% over the next five years and to total $31.8 billion by 2018.

Details of Nanomedicine Congress 2020

Conference Name

Place

Date

Nanomedicine Congress 2020

Venice, Italy

May 11-12, 2020

Read the rest here:
Nanomedicine Conferences 2019 | Nanotechnology Meetings ...

COVID-19 Impact on Nanomedicine Market Size, Latest Trends, Growth and Share 2020 to 2026| Clinical Cardiology, Urology, Genetics, Orthopedics -…

Posted on by

United States of America:-The Nanomedicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Nanomedicine market size is expected to gain market growth in the forecast period of 2020 to 2026, with a CAGR of xx% in the forecast period of 2020 to 2026 and will expected to reach USD xx million by 2026, from USD xx million in 2019.

Under COVID-19 Outbreak, how the Nanomedicine Industry will develop is also analyzed in detail in COVID Impact Chapter of this report.

For Better Understanding, Download FREE Sample Copy of Nanomedicine Market Report(Including full TOC, Graphs, Sample Data, and Tables)@ https://www.marketreportexpert.com/report/Nanomedicine/36175/sample

Some of top players influencing the Global Nanomedicine market:

Clinical Cardiology, Urology, Genetics, Orthopedics, Ophthalmology

Note: We can provide market report in regional language too, German/French/Japanese. We have researched the situation of COVID-19 thoroughly and Our new sample has been updated to reflect COVID-19 Impact on industry trends. We also offer a 25% discount.

Market segmentation

Nanomedicine market is split by Type and by Application. For the period 2015-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Majortype, primarily split into

Pharmaceuticals and Healthcare

Major applications/end users, including

Regenerative MedicineIn-vitro & In-vivo DiagnosticsVaccinesDrug Delivery

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert(Note: Our reports include the analysis of the impact of COVID-19 on this industry. Our updated sample pages shows impact of Covid-19 on Industry trends.): https://www.marketreportexpert.com/report/Nanomedicine/36175/inquiry

This report examines all the key factors influencing growth of global Nanomedicine market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Nanomedicine market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.

The Nanomedicine market is analysed and market size information is provided by regions (countries).

The key regions covered in the Nanomedicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Regional analysis is another highly comprehensive part of the research and analysis study of the global Nanomedicine market presented in the report. This section sheds light on the sales growth of different regional and country-level Nanomedicine markets. For the historical and forecast period 2015 to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nanomedicine market.

Get Table of Content, Tables, and Figures of Nanomedicine Market Report: https://www.marketreportexpert.com/report/Nanomedicine/36175/tableofcontent

Some of the key questions answered in this report:

What will the market growth rate, growth momentum or acceleration market carries during the forecast period?Which are the key factors driving the Nanomedicine market?What was the size of the emerging Nanomedicine market by value in 2020?What will be the size of the emerging Nanomedicine market in 2026?Which region is expected to hold the highest market share in the Nanomedicine market?What trends, challenges and barriers will impact the development and sizing of the Global Nanomedicine market?What is sales volume, revenue, and price analysis of top manufacturers of Nanomedicine market?What are the Nanomedicine market opportunities and threats faced by the vendors in the global Nanomedicine Industry?

The reports conclusion leads into the overall scope of the Global market with respect to feasibility of investments in various segments of the market, along with a descriptive passage that outlines the feasibility of new projects that might succeed in the Global Nanomedicine market in the near future. The report will assist understand the requirements of customers, discover problem areas and possibility to get higher, and help in the basic leadership manner of any organization. It can guarantee the success of your promoting attempt, enables to reveal the clients competition empowering them to be one level ahead and restriction losses.

About Us

Market Report Expert is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports.

Contact USJames ThompsonMarket Report ExpertPhone: +1-816-301-6258Email [emailprotected]Web:-https://www.marketreportexpert.com

https://farmingsector.co.uk/

Continued here:
COVID-19 Impact on Nanomedicine Market Size, Latest Trends, Growth and Share 2020 to 2026| Clinical Cardiology, Urology, Genetics, Orthopedics -...

Global Injectable Nanomedicines Market Projected to Reach USD 833.9 Million by the End of 2025 – MENAFN.COM

Posted on by

(MENAFN - GetNews) Rising adoption of minimally invasive treatments for chronic disorders across the globe will propel the growth of injectable nanomedicines market during the forecast period

Theglobalinjectable nanomedicines market touched USD 479.6 million in 2017, and is expected to reach USD 833.9 million by 2025, growing at a CAGR of 7.3% during 20182025.

Source: GMI Research

Major Factors driving the market growth are: Growing incidence of chronic diseases like cancer, cardiovascular diseases, neurological disorders Increasing research & development activities and clinical trials Rising demand and adoption of minimally invasive treatments Rising government and private funding Increasing geriatric population

Growing demand for minimal invasive treatments is driving the Injectable Nanomedicines market. Introduction of innovative and advanced nanotechnology and nanomedicines, especially in the emerging markets with the help of government and private funding would spur the growth of market for the injectable nanomedicines during the forecast period.

Request for Sample Report https://www.gmiresearch.com/report/global-injectable-nanomedicines-market-by-product/sample-request

A paradigm shifts from traditional therapeutics to novel therapeutics using nanomedicines is propelling the overall market as nanomedicines have higher payload capacity, prolonged blood circulation times, reduced toxicity and improved anti-tumour efficacy. Moreover, the application of injectable nanomedicines for some widespread chronic diseases like migraine and depression is also aiding market growth. The use of injectable nanomedicines are found to be efficient, lasting and easy treatment of many chronic cardiovascular and neurological disorders.

Growing incidence rate due to aging demographic patterns and the extension of health insurance coverage in a developing region will support the market growth. Advancements in cancer drug delivery and personalized cancer treatments, effective and safe treatment of medically refractory movement disorders and the need for fast and efficient cardiovascular systems will primarily drive the global injectable nanomedicine market.

'The rising pool of patients of chronic diseases and the need for a fast, efficient and long-lasting treatment with minimal invasion procedures will drive the injectable nanomedicines market.-GMI Research

Based on geography, North America held the largest market share in 2017 due to the significantly high rate of incidence of cancer as well as cardiovascular diseases in the region. Currently, the region has a growing demand for rapid research & development of novel nanomedicine in order to address unmet medical needs. Furthermore, favourable reimbursement policies and increasingly growing partnerships between leading enterprises and nanomedicine start-ups is also expected to create growth opportunities. Europe is the second largest market in 2017 and is promising market due to developed healthcare system and rising adoption of nanomedicine in oncology sector. Asia-Pacific is expected to show promising growth in global injectable nanomedicines during 2018-2025 due to the increasing government and private funding for health care infrastructure along with the rising incidence of neurological disorders. Moreover, increasing adoption of nanomedicine for the treatment of cancer, diabetes, cardiovascular diseases and some infectious disease in the Asia-Pacific region would also contribute significantly to the market growth for injectable nanomedicines in the region.

Request For Customization -https://www.gmiresearch.com/report/global-injectable-nanomedicines-market-by-product/request-for-customization

Based on geography, North America held the largest market share in 2017 due to the significantly high rate of incidence of cancer as well as cardiovascular diseases in the region. Currently, the region has a growing demand for rapid research & development of novel nanomedicine in order to address unmet medical needs. Furthermore, favourable reimbursement policies and increasingly growing partnerships between leading enterprises and nanomedicine start-ups is also expected to create growth opportunities. Europe is the second largest market in 2017 and is promising market due to developed healthcare system and rising adoption of nanomedicine in oncology sector. Asia-Pacific is expected to show promising growth in global injectable nanomedicines during 2018-2025 due to the increasing government and private funding for health care infrastructure along with the rising incidence of neurological disorders. Moreover, increasing adoption of nanomedicine for the treatment of cancer, diabetes, cardiovascular diseases and some infectious disease in the Asia-Pacific region would also contribute significantly to the market growth for injectable nanomedicines in the region.

Key takeaways/key essentials: In 2017, the cancer treatment held the major share for the injectable nanomedicines market followed by the cardiovascular diseases segment. High demand and adoption rate for minimally invasive treatments in the recent past. Extended research and development activities are taking place using the injectable nanomedicines regarding the concept of targeted drug delivery system.

Some of the key players operating in the global market for injectable nanomedicines include Merck & Co., Inc., Lupin, Pacira Pharmaceuticals Inc., Celgene Pharmaceutical Co. Ltd., Amgen, Inc., Janssen Biotech Inc., Pfizer Inc., Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch & Lomb Inc. among others.

The globalinjectable nanomedicines market has been segmented based on product type, indication type and key geographies. Based on the product type, global injectable nanomedicines market has been segmented into liposomes, micelles, nanocrystals and others. Based on indication type, the market has been segmented into cancers, central nervous system diseases, cardiovascular diseases, inflammatory diseases and others.

The research report ' global injectable nanomedicines market provides in-depth analysis of injectable nanomedicines market, globally, based on product type, indication and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers fuelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for injectable nanomedicines market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Report Analysis @https://www.gmiresearch.com/report/global-injectable-nanomedicines-market-by-product/

About GMI Research

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

Media Contact

Company Name: GMI RESEARCHContact Person: Media RelationsPhone: +353 1 442 8820Address:Level 1, The Chase Carmanhall Road, Sandyford Industrial EstateCity: DublinState: DublinCountry: IrelandWebsite: http://www.gmiresearch.com

Media Contact Company Name: GMI Research Pvt Ltd Contact Person: Media Relations Email: Send Email Phone: +91 124 421 1199 Address: Unit No, 505, 5th Floor, Tower B, Spazedge, Sohna Road City: Gurgaon State: Haryana Country: India Website: https://www.gmiresearch.com

MENAFN0810201900703268ID1099098272

Read this article:
Global Injectable Nanomedicines Market Projected to Reach USD 833.9 Million by the End of 2025 - MENAFN.COM

Nanomedicine Market: Industry Growth, Competitive Analysis, Future Prospects and Forecast 2026 – Chronicle Voice

Posted on by

The Nanomedicine Market is projected to grow at a rate of 12.6 percent by 2026, to reach USD 343.8 billion in 2026 from USD 132.8 billion in 2018.

The latest report, Nanomedicine market enables stakeholders to gain insights into their potential consumers to construct more effective marketing strategies for the forecast period, 2019 to 2026. Most importantly, the document empowers business owners to seek information about potential consumers and where they can find them. Apart from this, the literature sheds light on how major vendors operating in the Nanomedicine market are making the best use of their marketing campaigns. With an exclusive coverage of the top vendors, the study enables business owners to know more about the local market and locate potential consumers.

Request For Free PDF Sample Of This Research Report At: https://www.reportsanddata.com/sample-enquiry-form/1048

Besides, with real-time data available, the research identifies vital information about buyers such as their age, gender, spending power and end-use. This data can also be used to explore additional information about loyal consumers. The recent report on Nanomedicine market lets you understand what the recent market looks like. It helps product owners get a quick view of the potential buyers who is right around the business so that they can meet and better appeal their requirements. In addition, the study gets accurate statistics that can be used to start or expand the business, including the desired geography.

Companies considered and profiled in this market study

Arrowhead Pharmaceuticals, Inc., Nanospectra Biosciences, Inc., AMAG Pharmaceuticals, Bio-Gate AG, Celgene and Johnson & Johnson

Segments covered in the report:

This report forecasts volume and revenue growth at a global, regional & country level, and provides an analysis on the industry trends in each of the sub-segments from 2018 to 2025. For the purpose of this study, Reports and Data have segmented the global Nanomedicine Market on the basis of products, drug delivery system, application and region:

Products (Revenue, USD Billion; 2018-2026)

Drug Delivery System (Revenue, USD Billion; 2018-2026)

Application Outlook (Revenue, USD Billion; 2018-2026)

Regional Outlook (Revenue, USD Billion; 2018-2026)

Purchase Complete Nanomedicine Market Research Report At: https://www.reportsanddata.com/checkout-form/1048

The report not only empowers companies and individuals to understand the key characteristics of the target market but also the communication preferences. The audience can get the estimated size according to the number of sales in a specific region. By offering access to insights about the profit margin the study aims at improving the communication between the companies and potential customers. Armed with all required information on the recent development in the competitive landscape such as a joint venture, collaboration, acquisition and merger and product launch the study enables business owners to build a strong profile of their best buyers.

The market intelligence report on the Nanomedicine market further investigates the demographic as well as behavioural characteristics. Those planning on creating an effective marketing and sales campaign around potential segments are likely to benefit from the research. The extensive document includes a breakdown of all the key geographic characteristics, substitutes, lifestyle categories and marketing communication. Research provides companies and individuals access to data on customer requirements and off-the-shelf information on their spending capacity

The research provides answers to the following key questions:

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/nanomedicine-market

Originally posted here:
Nanomedicine Market: Industry Growth, Competitive Analysis, Future Prospects and Forecast 2026 - Chronicle Voice

RNA Nanoparticles Rubbery Properties Help Them To Target Tumors – Technology Networks

Posted on by

A new study by researchers at The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC James) shows that RNA nanoparticles have elastic and rubbery properties that help explain why these particles target tumors so efficiently and why they possess lower toxicity in animal studies.

RNA nanoparticles show great promise for the targeted delivery of anticancer drugs. Understanding their structure and behavior is essential for their possible future use.

This study, published in the journalACS Nano, reveals that RNA nanoparticles have elastic and rubbery properties that enable the molecules to stretch and return to their normal shape. Researchers say that these properties could help the particles target tumors by enabling them to slip through the poorly formed walls of tumor blood vessels and enter a tumor mass.

The researchers further proved that the same rubbery properties enable the RNA nanoparticle to slip through the kidney to excrete into the urine a half-hour after systemic injection, thereby eliminating them from the body relatively quickly. That, in turn, could reduce retention of the anticancer agent in vital organs, lowering an agents toxicity.

We show that RNA nanoparticles have a flexibility that allows for the assembly of molecular structures that have stretchable angles, says study leader and corresponding authorPeixuan Guo, PhD, professor in the College of Pharmacy and theSylvan G. Frank Endowed Chair in Pharmaceutics and Drug Delivery. Guo is also in the OSUCCC JamesTranslational Therapeutics Research Program.

These findings demonstrate the rubbery properties of RNA nanoparticles and why these molecules hold great promise for industrial and biomedical applications, especially as carriers for targeted delivery of anticancer drugs, says Guo, who directs Ohio StatesCenter for RNA Nanobiotechnology and Nanomedicine.

For this study, Guo and his colleagues tested the elasticity of nucleic acid polymers by stretching and relaxing individual RNA nanoparticle while subjecting RNA nanoparticles to elasticity studies using dual-beam optical tweezers built in Guo Lab. Finally, they used animal models to study the biodistribution, excretion and retention of RNA nanoparticles. This included measuring excretion of the particles in urine along with the study on the effect of their shape and size.

Key findings include:

Overall, Guo says, we believe these findings further support the development of RNA nanoparticles for targeted delivery of anticancer drugs or therapeutic RNA.

Reference: Ghimire C, Wang H, Li H, Vieweger M, Xu C, Guo P.RNA nanoparticles as rubber for compelling vessel extravasation to enhance tumor targeting and for fast renal excretion to reduce toxicity.ACS Nano 2020; doi:10.1021/acsnano.0c04863

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Continued here:
RNA Nanoparticles Rubbery Properties Help Them To Target Tumors - Technology Networks

NanoViricides Has Engaged Calvert Labs for Safety Pharmacology Studies of Its Drug for the Treatment of COVID-19 – BioSpace

Posted on by

SHELTON, CT / ACCESSWIRE / November 11, 2020 /NanoViricides, Inc.. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, today reported that it has engaged Calvert Labs, a contract research organization ("CRO"), for performing the Safety Pharmacology studies of its clinical drug candidate for the treatment of COVID-19.

The Company has been diligently working on advancing its drug candidates for the treatment of COVID-19 towards human clinical trials as rapidly as feasible.

The Company intends to perform certain core safety pharmacology studies to ensure safety of the drug candidates at Calvert Labs. The data from these studies will be used for filing an IND application. Prior to that, the Company also intends to file a pre-IND application with the U.S. Food and Drug Administration ("FDA") to obtain guidance.

The recent increase in COVID-19 cases worldwide has led scientists to suggest that this pandemic virus is expected to become a circulating virus. Influenza viruses and common cold viruses are other examples of circulating viruses. However, SARS-CoV-2 is more virulent, and thereby causes substantially greater morbidity and mortality than these other circulating viruses. Therefore, development of an effective drug to treat the disease caused by SARS-CoV-2 is very important.

A curative treatment for a virus such as SARS-CoV-2 coronavirus would require a multi-faceted attack that shuts down (i) the ability of the virus to infect host cells and simultaneously and (ii) the ability of the virus to multiply inside the host cells. The nanoviricide platform enables direct multi-point attack on the virus that is designed to disable the virus and its ability to infect new cells. At the same time, a nanoviricide is also capable of carrying payload in its "belly" (inside the micelle) that can be chosen to affect the ability of the virus to replicate. The nanoviricide is designed to protect the payload from metabolism in circulation. Thus, the nanoviricide platform provides an important opportunity to develop a curative treatment against SARS-CoV-2, the cause of COVID-19 spectrum of pathologies.

About Calvert Labs

For more than 40 years, Calvert Labs has been working with clients to help them develop the next generation of therapeutics aimed at extending and improving human life. Calvert are a collaborative development partner bringing extensive experience, an innovative, solutions-oriented approach and unsurpassed performance to your preclinical drug development programs.

About NanoViricidesNanoViricides, Inc. (the "Company")(www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. Our lead drug candidate is NV-HHV-101 with its first indication as dermal topical cream for the treatment of shingles rash. In addition, we are developing a clinical candidate for the treatment of COVID-19 disease caused by SARS-CoV-2 coronavirus. The Company cannot project an exact date for filing an IND for this drug because of its dependence on a number of external collaborators and consultants.

The Company is now working on performing required safety pharmacology studies and completing an IND application. The Company believes that since remdesivir already is US FDA approved, our drug candidate encapsulating remdesivir is likely to be an approvable drug, if safety is comparable. Remdesivir is developed by Gilead. The Company has developed our own drug candidates independently.

The Company intends to re-engage into an IND application to the US FDA for NV-HHV-101 drug candidate for the treatment of shingles once its COVID-19 project moves into clinical trials, based on resources availability. The NV-HHV-101 program was slowed down because of the effects of recent COVID-19 restrictions, and re-prioritization for COVID-19 drug development work.

The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides' platform technology and programs are based on the TheraCour nanomedicine technology of TheraCour, which TheraCour licenses from AllExcel. NanoViricides holds a worldwide exclusive perpetual license to this technology for several drugs with specific targeting mechanisms in perpetuity for the treatment of the following human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Rabies, Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), Influenza and Asian Bird Flu Virus, Dengue viruses, Japanese Encephalitis virus, West Nile Virus and Ebola/Marburg viruses. The Company has executed a Memorandum of Understanding with TheraCour that provides a limited license for research and development for drugs against human coronaviruses. The Company intends to obtain a full license and has begun the process for the same. The Company's technology is based on broad, exclusive, sub-licensable, field licenses to drugs developed in these areas from TheraCour Pharma, Inc. The Company's business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005.

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in preclinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products. FDA refers to US Food and Drug Administration. IND application refers to "Investigational New Drug" application. CMC refers to "Chemistry, Manufacture, and Controls".

Contact:NanoViricides, Inc.info@nanoviricides.com

Public Relations Contact:MJ ClyburnTraDigital IR clyburn@tradigitalir.com

Source: NanoViricides, Inc.

View source version on accesswire.com:https://www.accesswire.com/615993/NanoViricides-Has-Engaged-Calvert-Labs-for-Safety-Pharmacology-Studies-of-Its-Drug-for-the-Treatment-of-COVID-19

Read more from the original source:
NanoViricides Has Engaged Calvert Labs for Safety Pharmacology Studies of Its Drug for the Treatment of COVID-19 - BioSpace

Healthcare Nanotechnology (Nanomedicine) Market Competition, Status and Forecast, Market Size, Key Players, Regions, Growth Rate, Type, Application by…

Posted on by

The Healthcare Nanotechnology (Nanomedicine) Market report provides detailed information about key market dynamics such as detailed coverage, key trends, opportunities, historical and forecast market information, demand, application details, company shares and detailed information about Healthcare Nanotechnology (Nanomedicine) market structure. This market research report shows specific facts and figures on how the Healthcare Nanotechnology (Nanomedicine) market will grow over the forecast period.

This market research study is significant for manufacturers in the Healthcare Nanotechnology (Nanomedicine) market, including Healthcare Nanotechnology (Nanomedicine) stakeholders, distributors, suppliers, and investors, and it can also help them understand applicable strategies to grow in the Healthcare Nanotechnology (Nanomedicine) market. Stakeholders, investors, industry experts, as well as business researchers can influence the information and statistics offered in the market research report.

Get a Sample Copy of the Report at https://www.industryresearch.co/enquiry/request-sample/13339023

About Healthcare Nanotechnology (Nanomedicine) Market Report: Nanomedicine is a promising mode of cancer treatment. With the advantage of the properties of matter at nanoscale, nanomedicine promises to develop innovative drugs with greater efficacy and lesser side effects than standard therapies.

Top manufacturers/players: Abbott Laboratories, Combimatrix Corporation, GE Healthcare, Sigma-Tau Pharmaceuticals Inc., Johnson & Johnson, Mallinckrodt Plc, Merck & Company Inc., Nanosphere Inc., Pfizer, Inc., Celgene Corporation

Healthcare Nanotechnology (Nanomedicine) Market Segment by Regions-

The Healthcare Nanotechnology (Nanomedicine) Market report delivers a basic overview of the industry including its definition, applications and manufacturing technology. Also, the Healthcare Nanotechnology (Nanomedicine) Industry report explores the international Major Market players in detail.

Healthcare Nanotechnology (Nanomedicine) Market Segment by Type:

Healthcare Nanotechnology (Nanomedicine) Market Segment by Applications:

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13339023

Through the statistical analysis, the Healthcare Nanotechnology (Nanomedicine) Market report depicts the global market of Healthcare Nanotechnology (Nanomedicine) Industry including capacity, production, production value, cost/profit, supply/demand and import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.

Table of Contents:

1 Market Overview

2ManufacturersProfiles

3GlobalHealthcare Nanotechnology (Nanomedicine)Sales,Revenue,MarketShareandCompetitionbyManufacturer(2017-2018)

4GlobalHealthcare Nanotechnology (Nanomedicine)MarketAnalysisbyRegions

5NorthAmericaHealthcare Nanotechnology (Nanomedicine)byCountry

6EuropeHealthcare Nanotechnology (Nanomedicine)byCountry

7Asia-PacificHealthcare Nanotechnology (Nanomedicine)byCountry

8SouthAmericaHealthcare Nanotechnology (Nanomedicine)byCountry

9MiddleEastandAfricaHealthcare Nanotechnology (Nanomedicine)byCountries

10GlobalHealthcare Nanotechnology (Nanomedicine)MarketSegmentbyType

11GlobalHealthcare Nanotechnology (Nanomedicine)MarketSegmentbyApplication

12Healthcare Nanotechnology (Nanomedicine)MarketForecast(2019-2024)

13SalesChannel,Distributors,TradersandDealers

14ResearchFindingsandConclusion

15 Appendix

Continued

Purchase This Report (Price 3480 $ USD for a Single-User License) https://www.industryresearch.co/purchase/13339023

Contact Us:

Name: Ajay More

Phone:US +1424 253 0807 /UK +44 203 239 8187

Email:[emailprotected]

In the end, the Healthcare Nanotechnology (Nanomedicine) Market report makes some important proposals for a new project of Healthcare Nanotechnology (Nanomedicine) Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2013-2023 Global and Chinese Healthcare Nanotechnology (Nanomedicine) Market covering all important parameters.

Our Other Reports:

Lactic Starter Culture Industry: Global Market Overview, Shares, Growth, Demand and Forecast Report 2023

Core Drill Market Report 2019 With Top Countries Data: Analysis, Price and Gross Margin, Market Size, Competition by Manufacturers

Aviation Obstacle Lighting Industry: Global Market Overview, Shares, Growth, Demand, market Size, Production, Types & Applications and Forecast Report 2024

Sickle Cell Disease Treatment Market Business Opportunities, Market, Trend, Growth, Revenue, Manufacturers and Forecast from 2019-2023

Go here to see the original:
Healthcare Nanotechnology (Nanomedicine) Market Competition, Status and Forecast, Market Size, Key Players, Regions, Growth Rate, Type, Application by...

Center for Drug Delivery and Nanomedicine (CDDN

Posted on by

The need for the discovery and development of innovative technologies to improve the delivery of therapeutic and diagnostic agents in the body is widely recognized. The next generation therapies must be able to deliver drugs, therapeutic proteins and recombinant DNA to focal areas of disease or to tumors to maximize clinical benefit while limiting untoward side effects. The use of nanoscale technologies to design novel drug delivery systems and devices is a rapidly developing area of biomedical research that promises breakthrough advances in therapeutics and diagnostics.

Center for Drug Delivery and Nanomedicine (CDDN) serves to unify existing diverse technical and scientific expertise in biomedical and material science research at the University of Nebraska thereby creating a world class interdisciplinary drug delivery and nanomedicine program. This is realized by integrating established expertise in drug delivery, gene therapy, neuroscience, pathology, immunology, pharmacology, vaccine therapy, cancer biology, polymer science and nanotechnology at the University of Nebraska Medical Center (UNMC), the University of Nebraska at Lincoln (UNL) and Creighton University.

CDDNs vision is to improve health by enhancing the efficacy and safety of new and existing therapeutic agents, diagnostic agents and genes through the discovery and application of innovative methods of drug delivery and nanotechnology. CDDNs mission is to discover and apply knowledge to design, develop and evaluate novel approaches to improve the delivery of therapeutic agents, diagnostic agents and genes.

The COBRE Nebraska Center for Nanomedicine is supported by the National Institute of General Medical Science(NIGMS) grant 2P20 GM103480-07.

Read the original here:
Center for Drug Delivery and Nanomedicine (CDDN

Precision NanoSystems to Launch the Revolutionary Ignite – Yahoo Finance

Posted on by

A Disruptive Technology Enabling Transformative Medicine

Vancouver BC, Oct. 09, 2019 (GLOBE NEWSWIRE) -- Precision NanoSystems (PNI) a global leader of innovative solutions for the discovery, development, and manufacture of nanomedicine based gene and cell therapies, small molecule and protein based drugs is pleased to introduce our newest member of the Nanoassemblr Platform: the Ignite availabe October 15, 2019.

The Ignite embodies everything that made the NanoAssemblr family of instruments the go-to platform for developing new Precision and Gene Therapy medicines for over 100 biopharma companies and featured in over 150 publications. said James Taylor, CEO & Co-Founder PNI. The Ignite brings our latest innovations developed for clinical manufacturing to the bench, and paves the way for new nanomedicine approaches to treat cancer, rare disease and infectious disease.

PNIs proprietary NxGen scalable continuous-flow microfluidic technology is at the heart of the NanoAssemblr family, using controlled mixing to reproducibly manufacture the highest quality drug products through a single mixer across scales. Ignite enables rapid benchtop scale development of nanoparticle based RNA, DNA, CRISPR, small molecule and protein therapeutics. Optimized drug products are predictably scaled to advanced preclinical and clinical scale with the NxGen technology on the NanoAssemblr Blaze and GMP Systems.

As the leading provider of RNA/DNA drug manufacturing, we designed Ignite with the end in mind developing a robust, scalable process from the earliest stage. Enabling researchers to create transformative medicines at the bench scale, said Euan Ramsay, CCO & Co-Founder PNI.

We are hitting the road and showcasing this revolutionary technology in a location near you. Find localWorkshopsor see Ignite and our complete NanoAssemblr Platform at theseconferences in 2019.

About: PNIs proprietary NanoAssemblr Platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments,reagents and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology.

Attachments

Jane AllevaPrecision NanoSystems Inc.1+778 877 5473jalleva@precision-nano.com

Read the rest here:
Precision NanoSystems to Launch the Revolutionary Ignite - Yahoo Finance

Global Nanomedicine Market 2019-2024 Onset of Advanced Technologies to Upsurge the Growth – Materials Post

Posted on by

The NanomedicineMarket report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Additionally, the report also highlights market entry strategies for various companies across the globe along with pipeline and product analysis. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the Nanomedicinemarket. It has also covered and analyzed the potential of Nanomedicinemarket and provides statistics and information on market size, shares and growth factors.

Look insights of Global Nanomedicineindustry market research report athttps://www.pioneerreports.com/report/504625

About NanomedicineIndustry

The overviews, SWOT analysis and strategies of each vendor in the Nanomedicinemarket provide understanding about the market forces and how those can be exploited to create future opportunities.

Key Players in this Nanomedicinemarket are:

Get sample Copy of this NanomedicineMarket Report athttps://www.pioneerreports.com/request-sample/504625

Production Analysis:SWOT analysis of major key players ofNanomedicineindustry based on a Strengths, Weaknesses, companys internal & external environments. , Opportunities and Threats. . It also includesProduction, Revenue, and average product price and market shares of key players. Those data are further drilled down with Manufacturing Base Distribution, Production Area and Product Type. Major points like Competitive Situation and Trends, Concentration Rate Mergers & Acquisitions, Expansion which are vital information to grow/establish a business is also provided.

Product Segment Analysis of the NanomedicineMarket is:

Product Product Type Segmentation SegmentationQuantum dotsNanoparticlesNanoshellsNanotubesNanodevices

Industry SegmentationSegmentation encompasses oncologyInfectious diseasesCardiologyOrthopedics

Look into Table of Content of NanomedicineMarket Report at https://www.pioneerreports.com/TOC/504625

Regions Covered in NanomedicineMarket are:-

Inquire for further detailed information of NanomedicineMarket Report at:https://www.pioneerreports.com/pre-order/504625

NanomedicineMarket Report Highlights: The report provides a detailed analysis on current and future market trends to identify the investment opportunities Market forecasts till 2024, using estimated market values as the base numbers Key market trends across the business segments, Regions and Countries Key developments and strategies observed in the market NanomedicineMarket Dynamics such as Drivers, Restraints, Opportunities and other trends In-depth company profiles of key players and upcoming prominent players Growth prospects among the emerging nations through 2024 Market opportunities and recommendations for new investments

The report offers the market growth rate, size, and forecasts at the global level in addition as for the geographic areas: Latin America, Europe, Asia Pacific, North America, and Middle East & Africa. Also it analyses, roadways and provides the global market size of the main players in each region. Moreover, the report provides knowledge of the leading market players within the Nanomedicinemarket. The industry changing factors for the market segments are explored in this report. This analysis report covers the growth factors of the worldwide market based on end-users.

In this study, the years considered to estimate the market size of NanomedicineMarket are as follows:-

Single User Licence Price: USD 2350

No Of Pages in NanomedicineMarket Report: NOP

Purchase of NanomedicineMarket Report at:https://www.pioneerreports.com/checkout/504625

Read more:
Global Nanomedicine Market 2019-2024 Onset of Advanced Technologies to Upsurge the Growth - Materials Post

The Cutting Edge of Science, Homeopathy and Nanomedicine w/ Dana Ullman, MPH, CCH — Part I (of V) – Video

Posted on by


The Cutting Edge of Science, Homeopathy and Nanomedicine w/ Dana Ullman, MPH, CCH -- Part I (of V)
A presentation at San Francisco #39;s prestigious Commonwealth Club (September 17, 2014). The body of evidence for homeopathy and nanopharmacology is so much larger than most people realize, ...

By: Dana Ullman

Read more:
The Cutting Edge of Science, Homeopathy and Nanomedicine w/ Dana Ullman, MPH, CCH -- Part I (of V) - Video

Homeopathy & Nanomedicine in Chronic Disease and Immune Disorders – Dana Ullman – Video

Posted on by


Homeopathy Nanomedicine in Chronic Disease and Immune Disorders - Dana Ullman
Dana Ullman, MPH, CCH presents Homeopathy Nanomedicine in Chronic Disease and Immune Disorders on October 16, 2014 at Palo Alto, CA. DANA ULLMAN, MPH, CCH, is one of America #39;s ...

By: Silicon Valley Health Institute

More:
Homeopathy & Nanomedicine in Chronic Disease and Immune Disorders - Dana Ullman - Video

Healthcare Nanotechnology (Nanomedicine) Market Analysis by 19 Key Players, Types, Applications and Growth Opportunities to 2024 – Bulletin Line

Posted on by

The Global Healthcare Nanotechnology (Nanomedicine) Market provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Healthcare Nanotechnology (Nanomedicine) market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. The report provides key statistics on the market status of the Healthcare Nanotechnology (Nanomedicine) manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Complete report on Healthcare Nanotechnology (Nanomedicine) market spreads across 182 pages profiling companies and supported with tables and figures.

Our industry professionals are working reluctantly to understand, assemble and timely deliver assessment on impact of COVID-19 disaster on many corporations and their clients to help them in taking excellent business decisions. We acknowledge everyone who is doing their part in this financial and healthcare crisis.

Get Sample Copy of Healthcare Nanotechnology (Nanomedicine) market 2020-2024 at: https://www.insidemarketreports.com/sample-request/6/457728/Healthcare-Nanotechnology-Nanomedicine

Key Companies Analysis: Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, SmitH& Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Takeda, Ipsen, Endo International profiles overview.

This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Healthcare Nanotechnology (Nanomedicine) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analysed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The Global Healthcare Nanotechnology (Nanomedicine) Market focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Healthcare Nanotechnology (Nanomedicine) industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With the tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Major Points covered in this report are as below

The study objectives are:

Purchase the copy of this report at: https://www.insidemarketreports.com/buy-now/6/457728/Healthcare-Nanotechnology-Nanomedicine/single

Purchase this Report now by availing up to 40% Discount and free consultation.Limited Offer only.

Why Inside Market Reports:

For all your Research needs, reach out to us at:

Email: [emailprotected]

Phone: +1-617-230-0741

Read more:
Healthcare Nanotechnology (Nanomedicine) Market Analysis by 19 Key Players, Types, Applications and Growth Opportunities to 2024 - Bulletin Line